Close Menu

At the University of Pennsylvania, genome researchers have created a method for analyzing concordant genomic aberrations for determining important regions for tumor progression, according to a paper in PLoS Genetics. Using a method called Multiple Sample Analysis, they used microarrays to create profiles of conserved aberrations in certain cancer types, allowing them to validate targets for cancer therapies.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

IBM security researchers warn of a phishing campaign targeted at organizations involved in the distribution of SARS-CoV-2 vaccines, the Verge reports.

A researcher accused of smuggling research materials out of the US has pleaded guilty to making false statements, according to the Associated Press.

The Illinois police have cut the number of DNA tests waiting to be run in about half, CBS Chicago reports.

In Science this week: gene expression signature linked to nonalcoholic fatty liver disease progression, and more.